Report Detail
Global RAF Proto Oncogene Serine/Threonine Protein Kinase Market Insights, Forecast to 2025
- RnM2932320 |
- 12 February, 2019 |
- Global |
- 115 Pages |
- QYResearch |
- Pharma & Healthcare
The global RAF Proto Oncogene Serine/Threonine Protein Kinase market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the RAF Proto Oncogene Serine/Threonine Protein Kinase market based on company, product type, end user and key regions.
This report studies the global market size of RAF Proto Oncogene Serine/Threonine Protein Kinase in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of RAF Proto Oncogene Serine/Threonine Protein Kinase in these regions.
This research report categorizes the global RAF Proto Oncogene Serine/Threonine Protein Kinase market by top players/brands, region, type and end user. This report also studies the global RAF Proto Oncogene Serine/Threonine Protein Kinase market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Basilea Pharmaceutica AG
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Hanmi Pharmaceuticals, Co. Ltd.
Millennium Pharmaceuticals, Inc.
Novartis AG
Redx Pharma Plc
Sirnaomics, Inc.
VG Life Sciences, Inc.
Market size by Product
LXH-254
HM-95573
DCBCI-0902
BAL-3833
Others
Market size by End User
Solid Tumor
Colorectal Cancer
Liver Cancer
Lung Adenocarcinoma
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global RAF Proto Oncogene Serine/Threonine Protein Kinase market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of RAF Proto Oncogene Serine/Threonine Protein Kinase market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global RAF Proto Oncogene Serine/Threonine Protein Kinase companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of RAF Proto Oncogene Serine/Threonine Protein Kinase submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of RAF Proto Oncogene Serine/Threonine Protein Kinase are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of RAF Proto Oncogene Serine/Threonine Protein Kinase market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 RAF Proto Oncogene Serine/Threonine Protein Kinase Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global RAF Proto Oncogene Serine/Threonine Protein Kinase Market Size Growth Rate by Product
- 1.4.2 LXH-254
- 1.4.3 HM-95573
- 1.4.4 DCBCI-0902
- 1.4.5 BAL-3833
- 1.4.6 Others
- 1.5 Market by End User
- 1.5.1 Global RAF Proto Oncogene Serine/Threonine Protein Kinase Market Size Growth Rate by End User
- 1.5.2 Solid Tumor
- 1.5.3 Colorectal Cancer
- 1.5.4 Liver Cancer
- 1.5.5 Lung Adenocarcinoma
- 1.5.6 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global RAF Proto Oncogene Serine/Threonine Protein Kinase Market Size
- 2.1.1 Global RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue 2014-2025
- 2.1.2 Global RAF Proto Oncogene Serine/Threonine Protein Kinase Sales 2014-2025
- 2.2 RAF Proto Oncogene Serine/Threonine Protein Kinase Growth Rate by Regions
- 2.2.1 Global RAF Proto Oncogene Serine/Threonine Protein Kinase Sales by Regions
- 2.2.2 Global RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 RAF Proto Oncogene Serine/Threonine Protein Kinase Sales by Manufacturers
- 3.1.1 RAF Proto Oncogene Serine/Threonine Protein Kinase Sales by Manufacturers
- 3.1.2 RAF Proto Oncogene Serine/Threonine Protein Kinase Sales Market Share by Manufacturers
- 3.1.3 Global RAF Proto Oncogene Serine/Threonine Protein Kinase Market Concentration Ratio (CR5 and HHI)
- 3.2 RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue by Manufacturers
- 3.2.1 RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue by Manufacturers (2014-2019)
- 3.2.2 RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue Share by Manufacturers (2014-2019)
- 3.3 RAF Proto Oncogene Serine/Threonine Protein Kinase Price by Manufacturers
- 3.4 RAF Proto Oncogene Serine/Threonine Protein Kinase Manufacturing Base Distribution, Product Types
- 3.4.1 RAF Proto Oncogene Serine/Threonine Protein Kinase Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers RAF Proto Oncogene Serine/Threonine Protein Kinase Product Type
- 3.4.3 Date of International Manufacturers Enter into RAF Proto Oncogene Serine/Threonine Protein Kinase Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global RAF Proto Oncogene Serine/Threonine Protein Kinase Sales by Product
- 4.2 Global RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue by Product
- 4.3 RAF Proto Oncogene Serine/Threonine Protein Kinase Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global RAF Proto Oncogene Serine/Threonine Protein Kinase Breakdown Data by End User
6 North America
- 6.1 North America RAF Proto Oncogene Serine/Threonine Protein Kinase by Countries
- 6.1.1 North America RAF Proto Oncogene Serine/Threonine Protein Kinase Sales by Countries
- 6.1.2 North America RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America RAF Proto Oncogene Serine/Threonine Protein Kinase by Product
- 6.3 North America RAF Proto Oncogene Serine/Threonine Protein Kinase by End User
7 Europe
- 7.1 Europe RAF Proto Oncogene Serine/Threonine Protein Kinase by Countries
- 7.1.1 Europe RAF Proto Oncogene Serine/Threonine Protein Kinase Sales by Countries
- 7.1.2 Europe RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe RAF Proto Oncogene Serine/Threonine Protein Kinase by Product
- 7.3 Europe RAF Proto Oncogene Serine/Threonine Protein Kinase by End User
8 Asia Pacific
- 8.1 Asia Pacific RAF Proto Oncogene Serine/Threonine Protein Kinase by Countries
- 8.1.1 Asia Pacific RAF Proto Oncogene Serine/Threonine Protein Kinase Sales by Countries
- 8.1.2 Asia Pacific RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific RAF Proto Oncogene Serine/Threonine Protein Kinase by Product
- 8.3 Asia Pacific RAF Proto Oncogene Serine/Threonine Protein Kinase by End User
9 Central & South America
- 9.1 Central & South America RAF Proto Oncogene Serine/Threonine Protein Kinase by Countries
- 9.1.1 Central & South America RAF Proto Oncogene Serine/Threonine Protein Kinase Sales by Countries
- 9.1.2 Central & South America RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America RAF Proto Oncogene Serine/Threonine Protein Kinase by Product
- 9.3 Central & South America RAF Proto Oncogene Serine/Threonine Protein Kinase by End User
10 Middle East and Africa
- 10.1 Middle East and Africa RAF Proto Oncogene Serine/Threonine Protein Kinase by Countries
- 10.1.1 Middle East and Africa RAF Proto Oncogene Serine/Threonine Protein Kinase Sales by Countries
- 10.1.2 Middle East and Africa RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa RAF Proto Oncogene Serine/Threonine Protein Kinase by Product
- 10.3 Middle East and Africa RAF Proto Oncogene Serine/Threonine Protein Kinase by End User
11 Company Profiles
- 11.1 Basilea Pharmaceutica AG
- 11.1.1 Basilea Pharmaceutica AG Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Basilea Pharmaceutica AG RAF Proto Oncogene Serine/Threonine Protein Kinase Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Basilea Pharmaceutica AG RAF Proto Oncogene Serine/Threonine Protein Kinase Products Offered
- 11.1.5 Basilea Pharmaceutica AG Recent Development
- 11.2 Eli Lilly and Company
- 11.2.1 Eli Lilly and Company Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Eli Lilly and Company RAF Proto Oncogene Serine/Threonine Protein Kinase Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Eli Lilly and Company RAF Proto Oncogene Serine/Threonine Protein Kinase Products Offered
- 11.2.5 Eli Lilly and Company Recent Development
- 11.3 F. Hoffmann-La Roche Ltd.
- 11.3.1 F. Hoffmann-La Roche Ltd. Company Details
- 11.3.2 Company Business Overview
- 11.3.3 F. Hoffmann-La Roche Ltd. RAF Proto Oncogene Serine/Threonine Protein Kinase Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 F. Hoffmann-La Roche Ltd. RAF Proto Oncogene Serine/Threonine Protein Kinase Products Offered
- 11.3.5 F. Hoffmann-La Roche Ltd. Recent Development
- 11.4 Hanmi Pharmaceuticals, Co. Ltd.
- 11.4.1 Hanmi Pharmaceuticals, Co. Ltd. Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Hanmi Pharmaceuticals, Co. Ltd. RAF Proto Oncogene Serine/Threonine Protein Kinase Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Hanmi Pharmaceuticals, Co. Ltd. RAF Proto Oncogene Serine/Threonine Protein Kinase Products Offered
- 11.4.5 Hanmi Pharmaceuticals, Co. Ltd. Recent Development
- 11.5 Millennium Pharmaceuticals, Inc.
- 11.5.1 Millennium Pharmaceuticals, Inc. Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Millennium Pharmaceuticals, Inc. RAF Proto Oncogene Serine/Threonine Protein Kinase Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Millennium Pharmaceuticals, Inc. RAF Proto Oncogene Serine/Threonine Protein Kinase Products Offered
- 11.5.5 Millennium Pharmaceuticals, Inc. Recent Development
- 11.6 Novartis AG
- 11.6.1 Novartis AG Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Novartis AG RAF Proto Oncogene Serine/Threonine Protein Kinase Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Novartis AG RAF Proto Oncogene Serine/Threonine Protein Kinase Products Offered
- 11.6.5 Novartis AG Recent Development
- 11.7 Redx Pharma Plc
- 11.7.1 Redx Pharma Plc Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Redx Pharma Plc RAF Proto Oncogene Serine/Threonine Protein Kinase Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Redx Pharma Plc RAF Proto Oncogene Serine/Threonine Protein Kinase Products Offered
- 11.7.5 Redx Pharma Plc Recent Development
- 11.8 Sirnaomics, Inc.
- 11.8.1 Sirnaomics, Inc. Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Sirnaomics, Inc. RAF Proto Oncogene Serine/Threonine Protein Kinase Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Sirnaomics, Inc. RAF Proto Oncogene Serine/Threonine Protein Kinase Products Offered
- 11.8.5 Sirnaomics, Inc. Recent Development
- 11.9 VG Life Sciences, Inc.
- 11.9.1 VG Life Sciences, Inc. Company Details
- 11.9.2 Company Business Overview
- 11.9.3 VG Life Sciences, Inc. RAF Proto Oncogene Serine/Threonine Protein Kinase Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 VG Life Sciences, Inc. RAF Proto Oncogene Serine/Threonine Protein Kinase Products Offered
- 11.9.5 VG Life Sciences, Inc. Recent Development
12 Future Forecast
- 12.1 RAF Proto Oncogene Serine/Threonine Protein Kinase Market Forecast by Regions
- 12.1.1 Global RAF Proto Oncogene Serine/Threonine Protein Kinase Sales Forecast by Regions 2019-2025
- 12.1.2 Global RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue Forecast by Regions 2019-2025
- 12.2 RAF Proto Oncogene Serine/Threonine Protein Kinase Market Forecast by Product
- 12.2.1 Global RAF Proto Oncogene Serine/Threonine Protein Kinase Sales Forecast by Product 2019-2025
- 12.2.2 Global RAF Proto Oncogene Serine/Threonine Protein Kinase Revenue Forecast by Product 2019-2025
- 12.3 RAF Proto Oncogene Serine/Threonine Protein Kinase Market Forecast by End User
- 12.4 North America RAF Proto Oncogene Serine/Threonine Protein Kinase Forecast
- 12.5 Europe RAF Proto Oncogene Serine/Threonine Protein Kinase Forecast
- 12.6 Asia Pacific RAF Proto Oncogene Serine/Threonine Protein Kinase Forecast
- 12.7 Central & South America RAF Proto Oncogene Serine/Threonine Protein Kinase Forecast
- 12.8 Middle East and Africa RAF Proto Oncogene Serine/Threonine Protein Kinase Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 RAF Proto Oncogene Serine/Threonine Protein Kinase Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on RAF Proto Oncogene Serine/Threonine Protein Kinase . Industry analysis & Market Report on RAF Proto Oncogene Serine/Threonine Protein Kinase is a syndicated market report, published as Global RAF Proto Oncogene Serine/Threonine Protein Kinase Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of RAF Proto Oncogene Serine/Threonine Protein Kinase market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
